All In MedTech

Device Trial Radar · NCT07477054

A Post-Approval Multicenter Study to Assess the Continued Safety and Effectiveness of the AeroPace® System

A Post-Approval Multicenter Study to Assess the Continued Safety and Effectiveness of the AeroPace® System - The AERO-PAS Study

Last checked: Nov 20, 2026Latest source record: Oct 30, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

Recruiting

Status

Recruiting

Enrollment

120

Planned (sponsor's estimate)

Start

Oct 31, 2026

Primary completion

Aug 31, 2028

Study completion Sep 30, 2028

Sponsor

Lead sponsor
Lungpacer Medical Inc.Not on our public-company list
Sponsor type
Industry
First posted
Mar 17, 2026

More device trials from this sponsor

Design

Study type
Interventional
Phase
Not applicable (typical for device studies)
Allocation
Not applicable (single group)
Model
Single group
Masking
None
Primary purpose
Treatment
FDA-regulated device
Yes
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

A single-arm, prospective, multicenter cohort study to assess the 30-day continued safety and effectiveness of the AeroPace System in patients on mechanical ventilation (MV) at least 96 hours and who have not weaned. This is a study collecting real-world data in a post-market setting.

Conditions

  • Ventilator Induced Diaphragm Dysfunction

Interventions

  • Lungpacer Diaphragm Pacing TherapyDevice

    Transvenous phrenic nerve stimulation to induce diaphragm contraction.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Adverse Event ProfileTime frame: 30 days
  2. Successful WeaningTime frame: 30 days

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • Sutter Health Research Institute

    San Francisco, California · Recruiting

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.